According to Future Market Insights research, during the projected period, the Global animal antimicrobials and antibiotics market is expected to grow at a CAGR of 4.9%. The market value is projected to increase to USD 7,878.2 million by 2033.
Demand for animal antimicrobials and antibiotics is expected to rise as a result of the widespread use of various types of meat and milk in dairy products, notably in the western diet, and the rapid spread of similar eating habits worldwide.
| Attribute | Details |
|---|---|
| Animal Antimicrobials and Antibiotics Market Size Value in 2023 | USD 4,911.9 million |
| Animal Antimicrobials and Antibiotics Market Forecast Value in 2033 | USD 7,878.2 million |
| Global Animal Antimicrobials and Antibiotics Market Growth Rate (2023 to 2033) | 4.9% |
The market is growing due to factors like the rise in zoonotic illnesses, the demand for animal-derived food products, and the adoption of regulations to curb the spread of animal diseases. Due to rising demand for pet insurance and rising expenditures for veterinary care, this market share for animal antimicrobials and antibiotics is predicted to grow.
During the forecast period, animal antimicrobials and antibiotics market participants can anticipate tremendous development potential due to the untapped emerging markets of China, India, and Brazil, as well as the rise in the overall population of companion animals.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Research and Development
Sales of animal antimicrobials and antibiotics are soaring as a result of the leading companies' new medication innovations and enhanced research and development facilities, which are fueling the demand for effective treatment of animal diseases.
It is anticipated that increasing numbers of people own companion animals and are willing to spend money to ensure their health and welfare. This is likely to support the expansion of the animal health industry, which then fuels the demand for animal antimicrobials and antibiotics.
Government Initiatives
The development of early warning systems for the majority of animal diseases by a number of government and non-government groups has fueled the expansion of the global market for animal antibiotics and antimicrobials.
Restricting Factor
Strict regulatory requirements and rising use of antibiotic substitutes like feed enzymes and probiotics are some of the reasons partially limiting the growth of the global market for animal antibiotics and antimicrobials.
Human infections that are resistant to antibiotics can lengthen sickness times, increase hospital admissions, and treatment failures that are fatal. Nearly 400,000 people per year die from food-borne illnesses, with children under the age of five accounting for over one-third of these deaths, according to the WHO.
Therefore, veterinarians advise treating animals with less potent antibiotics. These actions could have a big impact on how frequently antibiotics are used worldwide.
In addition to organizing listening sessions across the nation to hear the concerns of both producers and veterinarians, FDA has been working closely with the American Veterinary Medical Association, other veterinary associations, and groups that represent animal producers.
Based on our outreach, they are convinced that veterinarians and animal producers are aware of their responsibility in ensuring the proper and prudent administration of the animal antimicrobials and antibiotics.
Medically significant animal antimicrobials and antibiotics can no longer be used for production if manufacturers voluntarily adopt these changes; instead, they must be ordered or prescribed by a qualified veterinarian in order to continue treating, controlling, or preventing disease in food animals.
FDA is presently investigating methods for strengthening current data gathering efforts in partnership with other agencies, such as USDA and CDC. FDA expects to seek additional public feedback, as it creates these improvements in animal antimicrobials and antibiotics.
The USA, European, and Japanese regulatory agencies are brought together by the Veterinary International Committee for Harmonization (VICH), which also harmonizes the rules and technical specifications for registering veterinary products.
Principal Consultant
Geographically, North America dominates the market for animal antibiotics and antimicrobials, owing to the region's high prevalence of animal disease outbreaks, excessive consumption of livestock products, prevalence of pet ownership, and elevated awareness of animal disease outbreaks.
The leading market participants in North America are also making significant financial investments in the creation of medicines to treat animal ailments, prompting the demand for animal antimicrobials and antibiotics.
On a global scale, the market for animal antibiotics and antimicrobials is expanding at the quickest rate in Asia Pacific. The region's rapid expansion is related to the rise in the number of animals, the demand for animal antibiotics, and the prevalence of animal diseases.
Additionally, the market for animal antibiotics and antimicrobials in the Asia Pacific region is expanding as a result of rising disposable income, a rise in the number of people owning pets as companions, and a rise in government involvement in the fight against the spread of animal diseases in developing nations such as India and China.
Asian nations are predicted to experience the highest growth in the demand for livestock products like beef, milk, mutton, pork, and poultry products, according to a 2018 FAO (Food and Agriculture Organization of the United Nations) survey on mapping the supply and demand for food sourced from animals.
An important development in the market for animal antibiotics and antimicrobials is the strategic collaboration. In order to conduct research and produce cutting-edge animal antibiotics and antimicrobials, companies are forming strategic alliances with key industry players.
Recent Developments in the Market
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
| Attribute | Details |
|---|---|
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2018 to 2022 |
| Market Analysis | USD million for Value and Units for Volume |
| Key Regions Covered | North America; Latin America; Europe; South Asia; East Asia; Oceania; MEA |
| Key Countries Covered | USA, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, South Korea, Australia, Brazil, Argentina, South Africa, UAE |
| Key Segments Covered | Product Type, Animal Type, Mode of Delivery, Region |
| Key Companies Profiled | Bayer AG; BoehringerIngelheim GmbH; CevaSanteAnimale; Dechra Pharmaceuticals PLC; Eli Lilly and Company; Merck & Co., Inc.; Sanofi; Vetoquinol S.A.; Virbac; Zoetis, Inc.; Elanco Animal Health; Phibro Animal Health; Virbac; Kyoritsu Seiyaku (Japan); Tianjin Ringpu; HIPRA; Zydus Animal Health; Inovet |
| Report Coverage | Market Forecast, Company Share Analysis, Competitive Landscape, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives |
| Customization & Pricing | Available upon Request |
The market is valued at USD 4,911.9 million in 2023.
The leading companies in the market are Zoetis, Merck, and Elanco.
The food industry is the primary consumer of the market.
The market is estimated to reach USD 7,878.2 million by 2033.
The market is expected to record a CAGR of 4.9% by 2033.
1. Executive Summary 2. Market Overview 3. Market Background 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product Type 5.1. Tetracyclines 5.2. Penicillins 5.3. Sulfonamides 5.4. Macrolides 5.5. Aminoglycosides 5.6. Lincosamides 5.7. Fluoroquinolones 5.8. Cephalosporins 5.9. Others 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Animal Type 6.1. Companion Animals 6.2. Food Producing Animals 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Mode of Delivery 7.1. Premixes 7.2. Oral Powder 7.3. Oral Solution 7.4. Injection 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 8.1. North America 8.2. Latin America 8.3. Western Europe 8.4. Eastern Europe 8.5. South Asia and Pacific 8.6. East Asia 8.7. Middle East and Africa 9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 15. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 16. Key Countries Market Analysis 17. Market Structure Analysis 18. Competition Analysis 18.1. Bayer AG 18.2. Boehringer Ingelheim GmbH 18.3. Ceva Sante Animale 18.4. Dechra Pharmaceuticals PLC 18.5. Eli Lilly and Company 18.6. Merck & Co., Inc. 18.7. Sanofi 18.8. Vetoquinol S.A. 18.9. Virbac 18.10. Zoetis, Inc. 18.11. Elanco Animal Health 18.12. Phibro Animal Health 18.13. Virbac 18.14. Kyoritsu Seiyaku (Japan) 18.15. Tianjin Ringpu 18.16. HIPRA 18.17. Zydus Animal Health 18.18. Inovet 19. Assumptions & Acronyms Used 20. Research Methodology
Explore Food and Beverage Insights
View Reports
Animal Antimicrobials and Antibiotics Market
